[ESPR] QoQ Quarter Result on 31-Dec-2002 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
30-Dec-2002
Financial Year
2002
Quarter
31-Dec-2002 [#Q4]
Profit Trend
QoQ- 5.17%
YoY- -4.33%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -6,563 -8,435 -7,406 -6,619 -6,980 -7,824 -7,303 -6.86%
Tax 578 922 633 692 177 888 314 50.14%
NP -6,563 -8,435 -7,406 -6,619 -6,980 -7,824 -7,303 -6.86%
Tax Rate - - - - - - - -
Total Cost 6,563 8,435 7,406 6,619 6,980 7,824 7,303 -6.86%
Ratio Analysis
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
EPS -1.42 -2.00 -1.76 -1.58 -1.67 -1.87 -1.75 -12.99%
EPS Diluted -1.42 -2.00 -1.76 -1.58 -1.67 -1.87 -1.75 -12.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.